AwardTape · Defense awards · Medical · Diagnostics and lab supplies · HT942525FE048
HT942525FE048: $61K delivery order to Mapp Biopharmaceutical, Inc
Mapp Biopharmaceutical, Inc holds a delivery order from Defense Health Agency with $61K obligated since Oct 2023, against a ceiling of $61K. Latest action Sep 16, 2025.
Human-derived monoclonal antibodies and recombinant antigens
| PIID | HT942525FE048 |
|---|---|
| Type | delivery order |
| Parent award | HT942525D0009 |
| Company | Mapp Biopharmaceutical, Inc |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Medical · Diagnostics and lab supplies |
| PSC | 6550 IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS |
| NAICS | 325413 IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING |
| Obligated since Oct 2023 | $61K |
| Total obligated (lifetime) | $61K |
| Ceiling (base and all options) | $61K |
| Base date | Sep 16, 2025 |
| Latest action | Sep 16, 2025 |
| End date | Feb 25, 2026 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Not competed under simplified acquisition |
| Place of performance | CA |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial